Standout Papers

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor 2020 2026 2022 202412.8k
  1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020)
    Markus Hoffmann, Hannah Kleine‐Weber et al. Cell

Immediate Impact

3 by Nobel laureates 49 from Science/Nature 204 standout
Sub-graph 1 of 12

Citing Papers

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
2024 Standout
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
2023 Standout
70 intermediate papers

Works of Georg Herrler being referenced

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells
2016
and 33 more

Author Peers

Author Last Decade Papers Cites
Georg Herrler 3453 12873 2705 3912 163 19.5k
Bart L. Haagmans 4006 16776 4691 3427 242 23.7k
Marcel A. Müller 3163 23260 3539 4669 138 30.4k
Andreas Nitsche 3177 12354 1009 5418 248 21.2k
Fang Li 1663 15692 3805 4073 145 20.3k
Wenhui Li 4917 10136 2312 4078 237 18.2k
Stefan Pöhlmann 3842 20706 2239 5661 226 29.9k
Markus Hoffmann 1644 13793 1180 3580 113 18.2k
Susan C. Baker 1599 9612 2878 3417 135 15.5k
Jason S. McLellan 4804 11473 1945 4502 139 16.7k
Hyeryun Choe 2454 11397 1841 4884 96 22.3k

All Works

Loading papers...

Rankless by CCL
2026